Recherche
-
The Burden of Potentially Inappropriate Medications in Chronic Polypharmacy
(Journal of Clinical Medicine. vol. 9, n° 11, pp. 3728, 2020-11-20)Article de revueLibre accès -
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study
(European Journal of Epidemiology. pp. 1-11, 2022-09-21)Article de revue -
Use of cardiovascular and antidiabetic drugs during COVID19 epidemic in France
(Fundamental & Clinical Pharmacology. vol. 36, n° S1, pp. 94-95, 2022-06)Article de revue -
Consommation de substances psychoactives à la Reunion et à Mayotte, départements français de l'Océan Indien
(Thérapie. vol. 73, n° 5, pp. 419-427, 2018-10)Article de revue -
Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
(BMC Infectious Diseases. vol. 20, n° 1, pp. 850, 2020-11-16)Article de revueLibre accès -
Du médicament psychoactif à l'addictovigilance dans le Code de la sante publique en France (1990-2017)
(Thérapie. vol. 74, n° 3, pp. 375-382, 2019)Article de revue -
Utilisation de la kétamine chez les patients ambulatoires : que pouvons-nous apprendre des pratiques actuelles ?
(Thérapie, 2022-01-24)Article de revue -
Adverse events reported for Mirena levonorgestrel-releasing intrauterine device in France and impact of media coverage
(British Journal of Clinical Pharmacology. vol. 85, n° 9, pp. 2126-2133, 2019-09)Article de revue -
Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database
(Drug Safety. vol. 43, n° 3, pp. 243-253, 2020)Article de revue -
Safety of levonorgestrel 52mg intrauterine system compared to copper intrauterine device: a population-based cohort study
(Contraception. vol. 99, n° 6, pp. 345-349, 2019)Article de revue